Superior and effective microbiome therapeutics


We use our knowledge of the gut microbiome and expertise in engineering biology and fermentation to develop superior live biotherapeutics. These are a novel class of drugs based on living bacteria found in the gut but engineered to deliver specific therapeutic molecules.


Our Clostridium Assisted Drug Development (CADD™) platform provides superior gut delivery to support a pipeline of drug candidates addressing multiple therapeutic areas associated with the gut microbiome.